Barclays
GDRX icon

Barclays’s GoodRx Holdings GDRX Stock Holding History

Barclays’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7 Sell
2
-191,654
-100% -$638K ﹤0.01% 5206
2026
Q2 		$552K Sell
191,656
-7,899
-4% -$20.1K ﹤0.01% 3153
2026
Q1 		$391K Sell
199,555
-112,910
-36% -$265K ﹤0.01% 3328
2025
Q4 		$847K Sell
312,465
-5
-0% -$16 ﹤0.01% 3555
2025
Q3 		$1.32M Buy
312,470
+172,216
+123% +$757K ﹤0.01% 3198
2025
Q2 		$698K Buy
140,254
+164
+0.1% +$712 ﹤0.01% 3567
2025
Q1 		$618K Sell
140,090
-25,838
-16% -$121K ﹤0.01% 3392
2024
Q4 		$772K Buy
165,928
+25,815
+18% +$142K ﹤0.01% 3550
2024
Q3 		$972K Buy
140,113
+130,219
+1,316% +$1.02M ﹤0.01% 3380
2024
Q2 		$77.2K Sell
9,894
-19,500
-66% -$144K ﹤0.01% 4030
2024
Q1 		$209K Buy
29,394
+9,483
+48% +$62.7K ﹤0.01% 4096
2023
Q4 		$133K Buy
19,911
+1,051
+6% +$5.92K ﹤0.01% 4557
2023
Q3 		$106K Buy
18,860
+351
+2% +$2.34K ﹤0.01% 3583
2023
Q2 		$102K Buy
18,509
+12,722
+220% +$68.5K ﹤0.01% 3551
2023
Q1 		$36.2K Hold
5,787
– – ﹤0.01% 4517
2022
Q4 		$27K Buy
5,787
+216
+4% +$1.06K ﹤0.01% 4749
2022
Q3 		$26K Sell
5,571
-36,612
-87% -$231K ﹤0.01% 3976
2022
Q2 		$250K Buy
42,183
+17,322
+70% +$193K ﹤0.01% 3317
2022
Q1 		$480K Buy
+24,861
New +$570K ﹤0.01% 2940

Other funds holding GDRX

LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Technology Crossover Management X
Technology Crossover Management X Menlo Park, California $648M AUM 23.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Steinberganna Wealth Management
Steinberganna Wealth Management Huntington, New York $233M AUM 22.27% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Achmea Investment Management
Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return

Barclays's GDRX Position: Q3 2026 in Review

Barclays reduced its GoodRx Holdings (GDRX) stake by 100% in Q3 2026, selling an estimated $638K and leaving 2 shares worth $7. The position accounts for ﹤0.01% of the portfolio, ranked #5206.

Barclays first reported a position in GDRX in Q1 2022 and has held it in 19 quarters since. The position peaked at $1.32M in Q3 2025. 62 funds tracked by Wall St. Rank hold GDRX as of Q3 2026.

  • Barclays held 2 shares of GoodRx Holdings worth $7 as of Q3 2026.
  • Barclays sold 191,654 GoodRx Holdings shares in Q3 2026, an estimated $638K.
  • GoodRx Holdings made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5206 holding.
  • Barclays first reported a position in GoodRx Holdings in Q1 2022 and has held it in 19 quarters since.
  • Barclays's GoodRx Holdings position peaked at $1.32M in Q3 2025.
  • 62 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.